High-Dose Antithrombin Therapy for Sepsis: Mechanisms of Action
Authors:
- Akio KidokoroAKAkio Kidokoro
- 1 November 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Shock
- Vol. 18 (5) , 389-394
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Influence of Antithrombin III on Coagulation and Inflammation in Porcine Septic ShockArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbitsAmerican Journal of Hematology, 1999
- EFFECT OF ANTITHROMBIN III SUPPLEMENTATION ON INFLAMMATORY RESPONSE IN PATIENTS WITH SEVERE SEPSISShock, 1998
- Clinical Experience with Antithrombin III Concentrates in Critically III Patients with Sepsis and Multiple Organ FailureSeminars in Thrombosis and Hemostasis, 1998
- Involvement of NF-κB Activation in Thrombin-Induced Human Vascular Smooth Muscle Cell ProliferationBiochemical and Biophysical Research Communications, 1994
- HEPATIC INTERCELLULAR COMMUNICATION IN SHOCK AND INFLAMMATIONShock, 1994
- Thrombin Receptor Agonist Peptide Decreases Thrombomodulin Activity in Cultured Human Umbilical Vein Endothelial CellsBiochemical and Biophysical Research Communications, 1994
- Antithrombin III replacement in animal models of acquired antithrombin III deficiencyBlood Coagulation & Fibrinolysis, 1994
- Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassayBiochemical and Biophysical Research Communications, 1989